TELA Bio, Inc. (TELA)
NASDAQ: TELA · Real-Time Price · USD
1.030
-0.050 (-4.63%)
May 12, 2025, 11:21 AM - Market open
TELA Bio Revenue
TELA Bio had revenue of $18.52M in the quarter ending March 31, 2025, with 11.55% growth. This brings the company's revenue in the last twelve months to $71.22M, up 12.78% year-over-year. In the year 2024, TELA Bio had annual revenue of $69.30M with 18.56% growth.
Revenue (ttm)
$71.22M
Revenue Growth
+12.78%
P/S Ratio
0.51
Revenue / Employee
$340,751
Employees
209
Market Cap
40.74M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
TELA News
- 20 hours ago - TELA Bio, Inc. (TELA) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - TELA Bio to Announce First Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - TELA Bio, Inc. (TELA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 2 months ago - TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - TELA Bio to Participate in Piper Sandler's 36th Annual Healthcare Conference - GlobeNewsWire
- 6 months ago - TELA Bio, Inc. (TELA) Q3 2024 Earnings Call Transcript - Seeking Alpha